Introduction {#sec1-1}
============

Tuberculosis (TB) is always the result of gross defects in social organization and in the management of individual lives. It is truly a social sin which can and must be stamped out.

The estimates of the global burden of disease caused by TB in 2009 are as follows: 9.4 million incident cases (range, 8.9--9.9 million), 14 million prevalent cases (range, 12--16 million), 1.3 million deaths among HIV-negative people (range, 1.2--1.5 million) and 0.38 million deaths among HIV-positive people (range, 0.32--0.45 million). Most cases were in the South-East Asia, African and Western Pacific regions (35%, 30% and 20%, respectively). An estimated 11--13% of incident cases were HIV-positive; the African Region accounted for approximately 80% of these cases. There were 5.8 million notified cases of TB in 2009, equivalent to a case detection rate (CDR, defined as the proportion of incident cases that were notified) of 63% (range, 60--67%), up from 61% in 2008. Of the 2.6 million patients with sputum smear-positive pulmonary TB in the 2008 cohort, 86% were successfully treated.

In 2010, there were 8.8 million (range, 8.5--9.2 million) incident cases of TB, 1.1 million (range, 0.9--1.2 million) deaths from TB among HIV-negative people and an additional 0.35 million (range, 0.32--0.39 million) deaths from HIV-associated TB.\[[@ref1]\]

The 20^th^ century opened with infectious diseases and witnessed therapeutic advances that promised control over them. At the close of the century there are abundant grim reminders that the history of infectious diseases is unfinished. There had been steady stream of anti-mycobacterium agents with ever broader spectrum of activity. There is an incoming tide of concern about the problems of antimicrobial resistance. In most of the conditions, either due to infection or stress or metabolic disturbance is the key factor in the integrity of immune system in direct or indirect manner. These factors may have a role in the spread of new or resurgent infectious diseases, the susceptibility being dependant on type and degree of immune perturbation. Ayurveda stresses the need to enhance the body immunity while following specific therapeutic regimen indicated for the condition. The main cause behind TB is lowered immunity. Considering preventive aspect of the disease, in spite of repeated failure and disappointment in the medical fraternity is engaged in trying to find a specific cure for the disease. Ayurveda has its complete solution in form of *Rasayana* Drugs (rejuvenating drugs). *Rasayana* has the potential to provide strength and immunity. The *Rasayana* therapy was established in ancient era in order to enhance self-defense mechanism of the body.

Considering the concept of *Rasayana* therapy, the present study is planned with the objectives to evaluate the i) efficacy of *Rasayana* compound as an adjuvant treatment of TB, ii) to design a therapeutic regimen for TB comparing of concomitant administration of the formulation with Anti-Koch\'s Treatment (AKT), and iii) how far the *Rasayana* compound is capable to counteract the Adverse Drug Reactions (ADR) caused by AKT and improve the quality of life of the patient

Materials and Methods {#sec1-2}
=====================

The study was conducted on 133 patients of TB (Category-I) selected from 1) I.P.G.T. and R. A. Hospital, Gujarat Ayurved University, Jamnagar, 2) District Tuberculosis Centre and Hospital, Jamnagar and 3) Guru Govind Singh Hospital, P. N. Marg, Jamnagar. They were randomly divided into two groups irrespective to sex and religion. The study is a single blind controlled study. Patients judged, eligible by the inclusion and exclusion criteria were formally informed about the study and those who consented were enrolled and randomly allotted to the study (n=79) and control (n=54) groups. The trial was conducted at OPD level.

Informed consent - The consent of patient was taken. The patients were free to withdraw from the study at any time without having to explain their action. The research study was cleared by Institutional Ethics Committee of I.P.G.T. and R.A.

Groups {#sec2-1}
------

### Group A (Control group) {#sec3-1}

The patients were given standard regimen of category I Pulmonary TB which includes administration of HRZE thrice a week on alternate days under RNTCP (Revised National Tuberculosis Control Programme) protocol.

Dose and drugs: i) Isoniazid (H) 600 mg, ii) Rifampicin (R) 450 mg, iii) Pyrazinamide (Z) 150 mg, iv) Ethambutol (E) 1200 mg Duration: 60 days (2 months); *Anupana*: Water

### Group B (Study group) {#sec3-2}

In study group, patients were administered Rasayana compound daily along with the standard regimen of AKT which include Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E) thrice a week on alternate days.

Dose and drugs: 450 mg capsule of *Rasayana* compound: Three capsules morning and two capsules evening.

Duration: 60 days (2 months) ; *Anupana*: Milk. Preparation of the drug (Rasayana compound): The composition formulation is depicted at [Table 1](#T1){ref-type="table"}. Spray-dried aqueous extracts were procured from Konark Herbal Pharmaceuticals, Vapi, Gujarat. Capsule filling was done at Pharmacy, Gujarat Ayurved University, Jamnagar, Gujarat.

###### 

Ingredients of *Rasayana* compound

![](Ayu-33-38-g001)

Inclusion Criteria: i) only sputum smear-positive patients from category I of pulmonary TB or extra pulmonary TB; ii) age group of \>13 years were selected for the present study.

Exclusion Criteria: i) complicated cases of pulmonary TB, pulmonary TB with HIV; ii) Age \< than 13 years; iii) seriously ill patients and those who suffered either hepatic injury or hepatitis in the last six months.

Diet Recommendation - All the patients registered in this study were advised to follow a normal routine diet as per the status of their *Agni*.

***Investigations***: The below investigations were carried out.

Hematological and biochemical investigations Hb gm%, TLC, DLC, ESR, C- reactive Protein (Quantitative), Peripheral smear; Liver Function tests: SGOT, SGPT, Serum Protein, A: G Ratio, Serum Bilirubin-Direct and Indirect, Serum Alkaline PhosphataseSputum smear examination for acid-fast bacilliRadiological investigations: X-ray chest PA view

Serious adverse events - Serious adverse events other than of AKT were neither expected nor encountered during the study course.

Observation and Results {#sec1-3}
=======================

It was observed from the demographic data that, 33.08% patients belonged to age group of 21-30 years. It shows that both women and men with TB are likely to be in their most reproductive age, i.e., 15-44 years.\[[@ref2]\] Maximum patients (70.67%) were male. which highlights that bio factors, like gender, influence of the susceptibility and immunity of different sexes towards TB. Religion-wise maximum patients (77.44%) were Hindus which reflects the hospital attendance and community distribution in Jamnagar and its surroundings.

Maximum patients were married (69.92%) as TB affects mostly the middle age group where most people get married. Previous studies indicate that the stigma associated with TB adds to the burden of disease for both men and women particularly if they are of marriageable age.\[[@ref3]\] The 22.55% patients were uneducated, 36.09% primary educated, 4.51% HSC and 3% were graduates. Lower educational status and illiteracy plays an important role and utterly follow unhygienic norms which may be the causes for prevalence of the disease in them. Occupation wise 48.87% patients were hard workers and 50.37% moderate workers which is suggestive of the influence of excessive exertion on disease manifestation. Establishing the *Sahasa* as major etiological factor the 39.09% patients were very poor, whereas 41.35% lower middle.

The 24.81% patients had positive family history. The problem lies in their failure to understand this complex disease. The early 'contagion theory' protagonists, including students of Hippocrates and other Greek scholars, were clearly on the right track.

Diet wise,79.69% patients were taking mixed food; it shows unhygienic nonvegetarian food sometimes hamper *Agni* and plays as a key factor in pathogenesis. Evaluating the dominant *Rasa*, maximum patients (79.69%) had a *Katu Rasa* dominant diet followed by *Lavana Rasa* dominant diet (45.86%). *Caraka Samhita* has elaborately discussed the symptoms caused due to extreme indulgences of *Katu Rasa*.\[[@ref4]\]

Maximum patients (62.41%) addicted to tobacco. It is well known and proven fact that tobacco addiction predisposes the individual to various respiratory system disorders. Tobacco smoking was associated with a two fold increased risk of active TB in a representative cohort of Taiwan\'s population. The finding that smoking increases the risk of TB suggests that tobacco control be considered as an important component in the global effort to eliminate TB.\[[@ref5]\] The 52.63% patients had *Madhyam Koshtha* and 30.07% had *Krura Koshtha*. *Kathina Malapravriti* (hard stool) was found in 30.40% patients whereas, 15% patients had *Drava Malapravriti* (loose stool) and 6% patients were having *Alpashamala Malapravriti* (less fecal matter). These may be considered as one of the associated causative factors of disease as it vitiates *Agni*. Maximum patients had *Vata Pradhana Pittaunubandhi Prakriti* (54.13%), followed by *vata pradhana kaphanubandhi* (37.59%) and *Kaphapradhana Pittanubandhi Prakriti* (6.01%) which highlights the association of *Vata Dosha* in constitution of the patients. 63.90% patients had *Rajasika Prakriti* and 35.33% *Tamasa Prakriti*. *Rajas* and *Tamasa* are the *Doshas* pertaining to mind and the types of morbidity caused by them are passion, anger, greed, attachment, envy, ego, pride, grief, worry, anxiety, fear, excitement, etc. *Avara Sara* was reported in 81.20% patients; *Avara Samhanana* 71.43%; *Avara Satmya* 87.96%; *Avara Vyayamshakti* 80.45%; *Avara Satwa* 78.19% and BMI \< 20 (71.43%) which was consider as *Avara Pramana*. All these conditions lead to lowered immunity and malnutrition. Agni wise *prakrititaha Ruchi* was *Pravara* in 60.15% patients and it converts in to Avara (91.725) at *Vikriti* condition. Moreover, *Abhyavaharana Shakti* in also converts Madhyam (46.62%) to *Avara* (84.21%) *Jarana Shakti*. *Prakritataha Madhyama* (47.36%) *Pravara* (30.82%) and *Avara Jarana Shakti* (21.80%) in contrast to *Vikriti* condition of *Madhyam Jarana Shakti* (51.12%) and *Avara Jarana Shakti* was obsereved in 48.87% of patients. The status of *Ruchi, Abhyavaharana Shakti* and *Jarana Shakti* in *Vikriti* condition shows hampered agni level in the disease condition.

Discussion {#sec1-4}
==========

In *Rasayana* compound-treated group, *Kasa* (cough) was relieved by 83% (*P* \< 0.001) whereas it was relieved by 43% (*P* \< 0.001) in Control group. The calculated value of χ^2^(45.21) is greater than the table value 18.47, corresponding to *P* \< 0.001, hence it is highly significant at 1% level. Thus, the drug *Rasayana* Compound with AKT is highly efficacious against Cough in comparison to control group. The patients of *Rajayakshma*, while coughing, spits out *Rasa* mixed with phlegm. Behind this coughing the pathogenesis of *Pratishyaya* play major role.\[[@ref6]\] In the patients whose head is filled up with vitiated *Vayu*, the *Kapha, Rakta* (blood) or *Pitta* located in the upper portion of the nasal passage, moves towards the Vayu as result of which *Pratishyaya*, which is of serious nature and causes emaciation of the body, is manifested. During excessive expectoration of phlegm, it is *Vayu* which stimulates the phlegm to come out. Therefore, the physician has to treat such a condition with the help of unctuous and hot remedies.\[[@ref7]\] In this pathogenesis *Vayu* plays major role so, the drugs like *Pippali, Haridra, Kustha, Kulinjana* as ingredients of *Rasayana* compound having *Tikshna, Ushna, Sukshma Gunas* are useful. *Phyllanthus emblica* shows a dose dependant cough suppressive effect at a minimum dose of 50 mg/kg body weight. A higher dose (200 mg/kg body wt.) orally was seen to be more effective in decreasing the number of cough efforts and frequency of cough.\[[@ref8]\] Glycyrrhetinic acid is a pentacyclic triterpenoid derivative of the β-amyrin type. It has expectorant and antitussive properties. Expectorants are used to decrease the viscosity of tenacious mucus, or to increase the secretion of mucus in dry irritant unproductive cough, thereby, lubricating the air passages and making coughing more productive.\[[@ref9]\]

Raktanisthivana disappeared in 87% patients in study group (*P* \< 0.01). However, in control group it was relieved with 76.19% (*P* \< 0.05). The calculated value of χ^2^ (1.163) is lower than the table value 3.36, corresponding to 0.5. Hence, it is insignificant. Thus the drug *Rasayana* Compound with AKT is not efficacious against hemoptysis in comparison to control group. In *Rajayakshma*, *Rakta* does not get nourished from *Rasa*. Therefore, quantity of other *Dhatus* is diminish. Even this small quantity of blood in the body gets accumulated because of obstruction in its channel of circulation to *Mamsa Dhatu*, etc. This blood instead of going downwards comes upwards to the throat.\[[@ref10]\] In this condition the use of drugs having *Ruksha, Snigdha* and *Sheeta Guna* are useful. *Rasayana* compound drugs like *Amalaki, Haridra, Kustha* have above qualities. *Shonitasthapana Dravyas* are also indicated in such condition; which restores blood in its pure form after eliminating its vitiating *Doshas*.\[[@ref11]\] Rasayana compound containing *Yashtimadhu* can be characterized under this category.

*Shwasa* was relieved by 71.3% in study group whereas it was relieved by 33.33% in control group both of which are statistically highly significant (*P* \< 0.001). The calculated value of χ^2^ (28.27) is greater than the table value 18.47, corresponding to 0.001, hence it is highly significant at 1% level. Thus the *Rasayana* Compound with AKT is highly efficacious against dyspnoea in comparison to control group. These patients suffer from *Shwasa* because of obstruction of *Pranavaha Srotas* by *Vayu* and *Kapha*\[[@ref12]\] and drugs having *Kaphaghna* and *Vataghna* propertiesare effective on it. *Rasayana* compound containing *Haridra, Pippali, Kustha, Kulinjan* and *Ashwagandha* falls in this category. *Amalaki, Guduchi* and *Sariva* having *Tridoshaghna* properties work on this condition. In Study group, *Jwara* (fever) was relieved by 93%, whereas in Control group it was relieved by 33.33% both of which were statistically highly significant (*P* \< 0.001). The calculated value of χ^2^ (12.06) is lower than the table value 13.28, corresponding to 0.01, hence it is insignificant. Thus the drug *Rasayana* Compound with AKT is not efficacious against fever in comparison to control group. *Guduchi* and *Pippali* both being *Pachaka*, *Ushna* and *Deepana* in nature causes *Aampachana* as well as relieves the provoked *Vata* and *Kapha* thus providing relief fever. *Guduchi* has been traditionally used in the treatment of fever. The animal studies have produced inconsistent results regarding its potential antipyretic activity.\[[@ref13]--[@ref15]\] Studies established significant anti-pyretic activity of different samples of *Guduchi Ghrita* (900 mg/kg, single dose) in yeast induced pyrexia.\[[@ref16]\] *Parshwashoola* was relieved by 79% in study group whereas it was relieved by 50.53% in control group both statistically highly significant (*P* \< 0.001). The calculated value of χ^2^ (24)is greater than the table value 18.47, corresponding to 0.001, hence it is highly significant at 1% level. It has smooth muscle relaxant and mild anti-inflammatory effect. In bronchial asthma this drug relaxes the bronchi and decreases the bronchial inflammation. The inflammatory process may be defined as a sequence of events that occurs in response to noxious stimuli infection. These responses are orchestrated by a highly modulated interaction between mediators of inflammation (e.g., cytokinase) and inflammatory cells. Cytokines represent a group of multifunctional substances that are involved in many steps of the inflammatory response. Cytokines are produced by both resident and migrating cells, macrophages and neutrophils and after release; they can act either locally or systemically. It has been widely shown that most cytokine actions involve the activation and transcription factors and protein kinases that, in turn regulate the expression of many target genes indispensable to the maintenance of the inflammatory state.

In study group decreased appetite was improved by 86% whereas it was improved by 42.06% in control group both of statistically highly significant (*P* \< 0.001). The calculated value of χ^2^ (55.97) is greater than the table value 18.47, corresponding to 0.001, hence it is highly significant at 1% level. Thus *Rasayana* compound with AKT is highly efficacious against decreased appetite in comparison to control group. This symptom is caused by the Dosha situated in *Aamashaya* and *Agni* vitiated by provoked Dosha and leads to formation of *Ama*. *Guduchi*, *Pippali* and *Kulinjana* are effective on this pathogenesis to wipe out *Ama* to make *Agni* active in the improvement of decreased appetite.

In study group fatigue was relieved by 75% whereas it was relieved by 39.72% in control group both are statistically highly significant (*P* \< 0.001). The calculated value of χ^2^ (46.37) is greater than the Table value 18.47, corresponding to 0.001, hence it is highly significant at 1% level. Thus *Rasayana* Compound with AKT is highly efficacious against fatigue in comparison to control group. Fatigue can be described as a range of afflictions, varying from a general state of lethargy to specific work induced fatigue. It can be both physical and mental. Physical fatigue is the inability to continue functioning at the level of one\'s abilities. It is ubiquitous in everyday life, but usually becomes particularly noticeable during heavy exercise. Mental fatigue on the other hand, rather manifests in somnolence. Fatigue, infection and oxidative stress are interrelated. The researches strongly suggest that during immunological activation, there is a significant increase in oxidative stress and curcumin can be a valuable option in the treatment of chronic fatigue syndrome.\[[@ref17]\] β-carotene and triptothen have nootropic activity which is present in Yastimadhu, works on immunological depression to inhibit the excess secretion of catecholamine and cortisone.

With regard to fatigue Ayurveda sees main issues as i) *Vata Doshas* (imbalanced *Vata* may be seen as an imbalance of the nervous system. This imbalance may cause insomnia, pain headaches, anxiety, sensitivity, etc.); ii) increase in toxic substances within the body (toxin pollution of the body changes the correct balance of the *Doshas* an may cause of the symptoms of fatigue); iii) Reduction of the body\'s ability to heal (immunity); iv) overuse, misuse or no use of mental or physical energy that may cause stress of different level (physical, mental, chronic, etc.)\[[@ref18]\] *Ratriprasweda* was relieved by 92% in study group, whereas it was relieved by 48.38% in control group both statistically highly significant (*P*\<0.001). The calculated value of χ^2^ (31.14) is greater than the Table value 18.47, corresponding to 0.001, hence it is highly significant at 1% level. Thus *Rasayana* Compound with AKT is highly efficacious against night sweating in comparison to control group.

Body weight was gained by 7.7% in study group whereas 2.04% in control group, both of which statistically highly significant (*P*\<0.001). Anabolic activity reported for *Amalaki* helps in increasing positive nitrogen balance and total protein level leads to increased body weight.\[[@ref19]\] In study group there was decrease in the total leukocyte count by 22.08% (positive result) which was statistically highly significant (*P*\<0.001). The level of Hb gm% was increased by 5.29% and decrease in ESR was by 47.12% both of which are statistically highly significant (*P*\>0.001) whereas the results in lymphocytes, eosinophils and monocytes were negative so no statistical scale could be applied. In control group, total leukocyte count was decreased by 21.26% (*P*\<0.01) and Hb gm% was increased by 6.29% (*P*\<0.01) and the ESR was decreased by 1.94% which was insignificant, whereas the results in lymphocytes, eosinophils and monocytes were negative so no statistical scale could be applied.

*Guduchi* appears to exert a variety of immunomodulatory effects including stimulation of phagocytic functions, macrophage and mitogenic activity, antibody responses, synthesis of interleukins, and humoral and cell-mediated immunity both *in vitro* and *in vivo*. The extract of Tinospora caused an increase in body weight, total hemoglobin and hepatic hexokinase.\[[@ref20]\] The ethanolic extract of *Saussurea lappa* was found to have exerted a stimulating effect on leukocyte phagocytic activity in dose-dependent manner which justifies its use in autoimmune and chronic inflammatory disorders.\[[@ref21]\] Curcumin is a potent immunomodulatory agent that can modulate the activation of T cells, B cells, macrophages, neutrophils, natural killer cells, and dendritic cells. Interestingly, however, curcumin at low doses can also enhance antibody responses.\[[@ref22]\] The C-reactive protein (quantitative) was decreased with statistically highly significant (*P*\<0.001) results in both the group; it shows improvement in acute inflammatory condition in this infectious disease. *Dhatukshaya Lakshana* improvement was found in *Meda* and *Rasa Kshaya* and it was statistically highly significant (*P*\<0.001) in study group whereas it was significant (*P*\<0.01) in control group. *Rakta Dhatu Kshaya* was also improved with significant level at (*P*\<0.01) in contrast to control group where it was insignificant. *Majja* and *Shukra Kshaya* were also improved with statistically highly significant (*P*\<0.001) results. All these improvements in *Dhatu Kshaya* were because of rejuvenating properties of *Rasayana* compound.

Conclusions {#sec1-5}
===========

The study revealed that simultaneous administration of general as well as organ-specific *Rasayana* drugs dealing with respiratory tract along with AKT provides better physical and mental well being to the patients by potentiating therapeutic efficacy of AKT and also counteracting the unwanted effects caused by AKT. *Rasayana* therapy has antioxidant effect along with nutritive value, immunomodulator, immunoprotective properties and free radical scavenging property. Hence, it has contributed significantly to achieve the goal of health for all particularly in National Health Programme to combat TB to make the ailing society healthy and happy.
